ABCA12 p.Gly1179Arg
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 21339420
[PubMed]
Rajpopat S et al: "Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases."
No.
Sentence
Comment
177
In our series, 2 missense mutations were identified, namely V1089F in exon 23 combined with a splice site mutation in exon 33 in one patient, and G1179R (homozygous) in exon 24 of another patient.
X
ABCA12 p.Gly1179Arg 21339420:177:146
status: NEW179 In our series, 2 missense mutations were identified, namely V1089F in exon 23 combined with a splice site mutation in exon 33 in one patient, and G1179R (homozygous) in exon 24 of another patient.
X
ABCA12 p.Gly1179Arg 21339420:179:146
status: NEW
PMID: 21168995
[PubMed]
Umemoto H et al: "New insight into genotype/phenotype correlations in ABCA12 mutations in harlequin ichthyosis."
No.
Sentence
Comment
35
Patient 2 carried a maternal missense mutation p.Gly1179Arg on the other locus (Fig. 1h).
X
ABCA12 p.Gly1179Arg 21168995:35:49
status: NEW36 To confirm the presence of the mutation p.Gly1179Arg in Patient 2, we performed restriction enzyme digestion analysis using BclI (NEW ENGLAND BioLabs).
X
ABCA12 p.Gly1179Arg 21168995:36:42
status: NEW38 The 255-bp PCR products from wild type alleles were not digested by BclI, although the PCR products from the allele with the mutation p.Gly1179Arg were digested into 173- and 82-bp fragments.
X
ABCA12 p.Gly1179Arg 21168995:38:136
status: NEW40 In contrast, the PCR product after BclI digestion from the mother of Patient 2 showed 255-, 173- and 82-bp bands, which indicated that she was heterozygous for the p.Gly1179Arg missense mutation (supplementary Fig. S1).
X
ABCA12 p.Gly1179Arg 21168995:40:166
status: NEW53 Patient 2 harboured two ABCA12 mutations, p.Arg1515X and p.Gly1179Arg, and both her parents were heterozygous carriers of these defects.
X
ABCA12 p.Gly1179Arg 21168995:53:59
status: NEW59 The mutation p.Gly1179Arg might result in major loss of ABCA12 function and/or structure, leading to the severe phenotype in Patient 2.
X
ABCA12 p.Gly1179Arg 21168995:59:15
status: NEW63 The marked difference in the clinical severity of the two patients indicated that the p.Gly1179Arg has far bigger deleterious functional effects than c.3295-2A>G.
X
ABCA12 p.Gly1179Arg 21168995:63:88
status: NEW
No.
Sentence
Comment
37
Although the vast majority of HI-associated ABCA12 mutations identified to date (this study) (Akiyama et al., 2005; Kelsell et al., 2005) (Figure 2) would result in a truncated protein, patient 95 was found to contain a homozygous missense substitution (G1179R) in the first transmembrane domain of ABCA12.
X
ABCA12 p.Gly1179Arg 16902423:37:254
status: NEW41 (b) Denaturing high-performance liquid chromatography traces of exon 24 showing patient 95 (homozygous G1179R), the mother of patient 95 (heterozygous), and a wild-type control.
X
ABCA12 p.Gly1179Arg 16902423:41:103
status: NEW44 G1179R was not detected by denaturing high-performance liquid chromatography mutation screening in one hundred unrelated controls of mixed ethnicity.
X
ABCA12 p.Gly1179Arg 16902423:44:0
status: NEW75 W199* and Q228* Q354* Y377* R714* R1297* G1179R W1294* Q2161* R1881* W1744* R2203* D2363N Del 28-53 Del 23 Del T Del 8 Del G Del A Del CG Del C Ins T ABCA12 Exon 6 8 9 10 16 17 23 24 27 28 33 34 37 42 44 47 49 53 Figure 2.
X
ABCA12 p.Gly1179Arg 16902423:75:41
status: NEW86 In this study, we have identified another missense substitution (G1179R) in exon 24 (homozygous in patient 95) that would substitute a glycine (uncharged polar residue) for an arginine (positively charged residue) in the first transmembrane domain of the protein.
X
ABCA12 p.Gly1179Arg 16902423:86:65
status: NEW123 The primers used for denaturing high-performance liquid chromatography analysis of G1179R in exon 24 are forward primer (50 -CGGACTACAGCTTCTCGGTTA-30 ) and reverse primer (50 -AAT TTCCCACTCTGCCATTC-30 ) to amplify a product of 205 bp.
X
ABCA12 p.Gly1179Arg 16902423:123:83
status: NEW132 Denaturing high-performance liquid chromatography (Transgenomic WAVE system, France) was used to assess whether the exon 24 sequence variant G1179R found in patient 95 was likely to be a mutation or a polymorphism.
X
ABCA12 p.Gly1179Arg 16902423:132:141
status: NEW133 The 205 bp fragment of exon 24 was analyzed in 100 control individuals plus patient and maternal samples, which are homozygous and heterozygous for G1179R, respectively.
X
ABCA12 p.Gly1179Arg 16902423:133:148
status: NEW